BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32748055)

  • 21. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study.
    Palomba S; Zupi E; Russo T; Falbo A; Del Negro S; Manguso F; Marconi D; Tolino A; Zullo F
    Hum Reprod; 2007 Feb; 22(2):578-85. PubMed ID: 17050549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
    Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.
    Uzan C; Muller E; Kane A; Rey A; Gouy S; Bendiffallah S; Duvillard P; Fauvet R; Darai E; Morice P
    Ann Oncol; 2014 Jan; 25(1):166-71. PubMed ID: 24287939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J; Brännström M
    Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
    Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
    Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).
    Koskas M; Uzan C; Gouy S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Hum Reprod; 2011 Apr; 26(4):808-14. PubMed ID: 21262776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
    Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
    Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: A systematic review and meta-analysis.
    Raimondo D; Raffone A; Zakhari A; Maletta M; Vizzielli G; Restaino S; Travaglino A; Krishnamurthy S; Mabrouk M; Casadio P; Mollo A; Scambia G; Seracchioli R
    Gynecol Oncol; 2022 Apr; 165(1):184-191. PubMed ID: 35090745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
    Guo L; Kang X; Su Y; Liu X; Xie W; Meng S; Liu Y; Wang W; Wang C
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():107-113. PubMed ID: 38422803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
    Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
    Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis.
    Huang Y; Zhang W; Wang Y
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):319-25. PubMed ID: 27343308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.
    Lu Z; Li B; Gu C
    J Int Med Res; 2019 Oct; 47(10):4895-4903. PubMed ID: 31432738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
    Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
    Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Borderline ovarian tumor in pregnancy: can surgery wait? A case series.
    Vidal Urbinati AM; Iacobone AD; Di Pace RC; Pino I; Pittelli MR; Guerrieri ME; Preti EP; Franchi D
    Arch Gynecol Obstet; 2021 Dec; 304(6):1561-1568. PubMed ID: 33950305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
    Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
    Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative surgery for borderline ovarian tumors--emphasis on fertility preservation. A review.
    Koutlaki N; Dimitraki M; Zervoudis S; Sofiadou V; Grapsas X; Psillaki A; Nikas I; Galazios G; Liberis V; Voiculescu S; Burcoş T
    Chirurgia (Bucur); 2011; 106(6):715-22. PubMed ID: 22308907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature.
    Bercow A; Nitecki R; Brady PC; Rauh-Hain JA
    J Minim Invasive Gynecol; 2021 Mar; 28(3):527-536.e1. PubMed ID: 32861046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.
    Romeo M; Pons F; Barretina P; Radua J
    World J Surg Oncol; 2013 Jan; 11():13. PubMed ID: 23343188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.